Prosecution Insights
Last updated: October 04, 2026

DLA Piper LLP (US)

Technology area: Biotechnology & Pharmaceuticals

76 pending office actions • 51 clients • 75 examiners • 44 art units • 0 of 76 (0%) have an AI response strategy ready

Analysis

DLA PIPER LLP (US) manages 21138 career applications, with a technology focus on Biotechnology & Pharmaceuticals. The firm maintains a resolved allowance rate of 84.42 percent. An average of 3.69 office actions is required to secure an allowance. There are 60 pending office actions currently.

The 84.42 percent allowance rate is the primary success metric for the 21138 career applications handled by the firm. The 3.69 average office actions per allowance reflect the prosecution path. The 60 pending office actions indicate the firm's ongoing activity.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=21138 apps, methodology: how we score firms)

84.4%
Allowance Rate
n=21138
+0.61σ
Allowance Rate (norm)
n=21138
3.7
OAs to Allowance
n=14298
+0.04σ
OAs to Allow (norm)
n=14298
1078 days
Time to Allowance
n=14298
+7.8pp
Interview Lift
n=21138
29.9%
RCE Rate
n=21138
2.4%
Appeal Rate
n=21138

Rejection Performance (% of received rejections ultimately overcome)

81.1%
§101 Overcome
n=2066
82.5%
§102 Overcome
n=5673
82.7%
§103 Overcome
n=9490
84.1%
§112 Overcome
n=5941

Specialization & Scale

G06F, G06Q, A61K
Top CPC Subclasses
12%
Top-3 CPC Share
n=21138
29
Practitioners
n=21138
728.9
Apps / Practitioner
n=21138

Portfolio Summary

76
Total Pending OAs
51
Non-Final OAs
24
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
1
Due this week
5
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 7 days (1)Due ≤ 30 days (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

33
Hard (43%)
34
Medium (45%)
8
Easy (11%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 + other9 (12%)
§103 only14 (18%)
§102 only4 (5%)
§112 only5 (7%)
Double-patenting only3 (4%)
Double-patenting + other16 (21%)
Multi-statute (no §101)24 (32%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

34
Life Sciences
45% of docket
6
Information Tech
8% of docket
7
Communications
9% of docket
2
Semiconductors
3% of docket
8
Mechanical / Eng
11% of docket
19
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

760 h
Manual time on pending OAs
152 h
Time saved (low, 20%)
266 h
Time saved (mid, 35%)
6.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HINDI, NABIL Z 2 87.4% +8.9%
POE, KEVIN T 1 39.4% +16.4%
KLIMOWICZ, WILLIAM JOSEPH 1 80.9% +18.2%
STOCK JR, GORDON J 1 81.5% +17.5%
HANKS, BENJAMIN L 1 21.4% +30.3%
ANDERSEN, KRISTOPHER E 1 70.5% +39.9%
KIM, MICHELLE JINJU 1 70.0% +50.0%
GIARDINO JR, MARK A 1 84.6% +2.5%
TUMEBO, TSION M 1 66.5% +20.2%
HOAG, MITCHELL BRAIN 1 70.4% +18.8%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19359507 Noble Metal Coated Plasmonic Waveguide Blocker For Heat Assisted Magnetic Recording Head HINDI, NABIL Z —
19355198 Tapered Optical And Magnetic Elements For Improved Writing In Heat-Assisted Magnetic Recording HINDI, NABIL Z —
19235519 SURFACE ANALYSIS OF GEMSTONES STOCK JR, GORDON J —
19181816 PARAMETER ENHANCED SEQUENTIAL PROGRAMMING METHOD GIARDINO JR, MARK A —

Hard Cases (33)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18660113 VOICE ASSISTANCE SYSTEM AND METHOD FOR HOLDING A CONVERSATION WITH A PERSON ABEBE, DANIEL DEMELASH 89d overdue
17838115 METHOD AND SYSTEM FOR IMPROVED MANAGEMENT OF GENETIC DISEASES MINCHELLA, KAITLYN L 59d overdue
18660163 INTERACTIVE AI TOY CAPABLE OF HOLDING A CONVERSATION WITH A PERSON, AND METHOD OF INTERACTING WITH SAME GRANT, MICHAEL CHRISTOPHER 44d overdue
17399920 CLASSIFICATION OF SUBTYPES OF KIDNEY TUMORS USING DNA METHYLATION GOLDBERG, JEANINE ANNE 42d overdue
18218953 Accelerometer-Based Voice Activity Detection With Optimized Detection Axis OPSASNICK, MICHAEL N 8d overdue
19314513 NETWORKED EVENT RESPONSE SYSTEM POE, KEVIN T —
19288651 Gimbal Strut Configuration With A No Mid Strut Design KLIMOWICZ, WILLIAM JOSEPH —
19235420 SYSTEMS AND METHODS FOR DRUG INTERACTION ANALYSIS HANKS, BENJAMIN L —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19184880 Head Gimbal Assembly With Gimbal Tethers For Hard Disk Drive Device KIM, MICHELLE JINJU 24d overdue
19314513 NETWORKED EVENT RESPONSE SYSTEM POE, KEVIN T —
19288651 Gimbal Strut Configuration With A No Mid Strut Design KLIMOWICZ, WILLIAM JOSEPH —
19235519 SURFACE ANALYSIS OF GEMSTONES STOCK JR, GORDON J —
19235420 SYSTEMS AND METHODS FOR DRUG INTERACTION ANALYSIS HANKS, BENJAMIN L —
19217164 DATA VISUALIZATION IMPLEMENTATION ANDERSEN, KRISTOPHER E —
19048001 SAMPLE ILLUMINATION SYSTEMS AND RELATED METHODS TUMEBO, TSION M —
18993959 LOCKING DEVICE, SYSTEM AND METHOD OF USE THEREOF HOAG, MITCHELL BRAIN —

Client Portfolio (51 clients)

Top Art Units

Art UnitApps
26885
36922
37712
16992
16252
16542
16822
16432
16842
16862

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19359507 Noble Metal Coated Plasmonic Waveguide Blocker For Heat Assisted Magnetic Recording Head Headway Technologies, Inc. HINDI, NABIL Z 2688 §102 Non-Final OA — Pending Oct 15, 2025
19355198 Tapered Optical And Magnetic Elements For Improved Writing In Heat-Assisted Magnetic Recording Headway Technologies, Inc. HINDI, NABIL Z 2688 DP Non-Final OA — Pending Oct 10, 2025
19314513 NETWORKED EVENT RESPONSE SYSTEM Pax Markets, Inc. POE, KEVIN T 3692 §101§102§112 Final Rejection — Pending Aug 29, 2025
19288651 Gimbal Strut Configuration With A No Mid Strut Design Magnecomp Corporation KLIMOWICZ, WILLIAM JOSEPH 2688 §102§103 Non-Final OA — Pending Aug 01, 2025
19235519 SURFACE ANALYSIS OF GEMSTONES Gemological Institute Of America, Inc. (Gia) STOCK JR, GORDON J §112Other Non-Final OA — Pending Jun 11, 2025
19235420 SYSTEMS AND METHODS FOR DRUG INTERACTION ANALYSIS Blue Genes Lab, LLC HANKS, BENJAMIN L 3684 §101§103DP Final Rejection — Pending Jun 11, 2025
19217164 DATA VISUALIZATION IMPLEMENTATION Data Visualization Software Lab ANDERSEN, KRISTOPHER E 2159 DP Final Rejection — Pending May 23, 2025
19184880 Head Gimbal Assembly With Gimbal Tethers For Hard Disk Drive Device Magnecomp Corporation KIM, MICHELLE JINJU 2688 §103 Final Rejection 24d overdue Pending Apr 21, 2025
19181816 PARAMETER ENHANCED SEQUENTIAL PROGRAMMING METHOD Silicon Storage Technology, Inc. GIARDINO JR, MARK A 2135 §103 Final Rejection — Pending Apr 17, 2025
19048001 SAMPLE ILLUMINATION SYSTEMS AND RELATED METHODS Gemological Institute Of America, Inc. TUMEBO, TSION M §103 Non-Final OA — Pending Feb 07, 2025
18993959 LOCKING DEVICE, SYSTEM AND METHOD OF USE THEREOF Mvrx, Inc. HOAG, MITCHELL BRAIN 3771 §102§103 Non-Final OA — Pending Jan 13, 2025
19011046 BOOST CONVERTER OUTPUT PROTECTION SYSTEMS AND METHODS Analog Devices, Inc. PEREZ, BRYAN REYNALDO 2838 §102§103 Non-Final OA — Pending Jan 06, 2025
18957521 Configurable Components For Shape Memory Alloy (SMA) Actuators Hutchinson Technology Incorporated AYALA DELGADO, ANTHONY §102 Non-Final OA — Pending Nov 22, 2024
18865516 IN-RACK FIRE DETECTION AND EXTINGUISHING SYSTEM AND METHOD Factory Mutual Insurance Company SUTHERLAND, STEVEN M §102§103§112 Non-Final OA — Pending Nov 13, 2024
18926282 DYNAMIC ERROR QUANTIZER TUNING SYSTEMS AND METHODS Maxim Integrated Products, Inc. WOLF, DARREN E §112 Non-Final OA — Pending Oct 24, 2024
18897817 PROTECTING SENSITIVE DATA IN TEXT-BASED GEN-AI SYSTEM Baffle, Inc. WHITE, JOSHUA RAYMOND 2438 §103§112 Final Rejection — Pending Sep 26, 2024
18844687 ENHANCING OPITCAL NONLINEARITY THROUGH XPM TEMPORAL TRAPPING NTT Research, Inc. CRAVER, CHARLES R §103§112 Non-Final OA — Pending Sep 06, 2024
18807451 BONE IMPLANT DEVICE Sleep Mechanics LLC WOZNICKI, JACQUELINE §103§112 Non-Final OA — Pending Aug 16, 2024
18803363 METHOD OF FORMING RESISTIVE RANDOM ACCESS MEMORY (RRAM) CELLS Silicon Storage Technology, Inc. FOX, BRANDON C §102§103 Non-Final OA — Pending Aug 13, 2024
18834562 METHOD OF ADMINISTRATION OF BRYOSTATIN FOR THE INDUCTION OF TUMOR ASSOCIATED ANTIGENS Bryologyx Inc. SCHMIDT, IZABELA MARIA §102§103§112 Non-Final OA — Pending Jul 30, 2024
18789670 BUOYANT CONTAINMENT AND/OR FILTRATION Innermost Containment Systems LLC MAYO, TARA LEIGH §102§103 Non-Final OA — Pending Jul 30, 2024
18660163 INTERACTIVE AI TOY CAPABLE OF HOLDING A CONVERSATION WITH A PERSON, AND METHOD OF INTERACTING WITH SAME Friendlybuzz Company, Pbc GRANT, MICHAEL CHRISTOPHER 3715 §101§102§103 Non-Final OA 44d overdue Pending May 09, 2024
18660113 VOICE ASSISTANCE SYSTEM AND METHOD FOR HOLDING A CONVERSATION WITH A PERSON Friendlybuzz Company, Pbc ABEBE, DANIEL DEMELASH 2657 §102§103 Final Rejection 89d overdue Pending May 09, 2024
18643988 INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS Orphai Therapeutics Inc. GULLEDGE, BRIAN M 1699 §103§112 Final Rejection — Pending Apr 23, 2024
18637265 SEMICONDUCTOR DEVICE WITH NON-PLANAR MOSFET DEVICE DIE AND PLANAR MOSFET DEVICE DIE Silicon Storage Technology, Inc. LEBENTRITT, MICHAEL §102 Non-Final OA — Pending Apr 16, 2024
18700649 THYMIC CELLS AND METHODS OF MAKING Thymmune Therapeutics, Inc. BATES, KEENAN ALEXANDER 1631 §102§103§112 Non-Final OA — Pending Apr 11, 2024
18626241 LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF Dechra Veterinary Products, LLC ALLEY, GENEVIEVE S 1617 §103§112DP Non-Final OA — Pending Apr 03, 2024
18694362 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME Curasen Therapeutics, Inc. ROZOF, TIMOTHY R 1625 §102§112DP Non-Final OA — Pending Mar 21, 2024
18612900 THREAD LOCAL EVENT BASED PROFILING WITH PERFORMANCE AND SCALING ANALYSIS Maxon Computer GmbH ABSHER, LUCAS DONALD §103§112 Non-Final OA — Pending Mar 21, 2024
18610195 UNIVERSAL METHOD FOR EXTRACTING NUCLEIC ACID MOLECULES FROM A DIVERSE POPULATION OF ONE OR MORE TYPES OF MICROBES IN A SAMPLE Sun Genomics, Inc. BELLAH, JEFFREY LAWRENCE §101§103§112DP Non-Final OA — Pending Mar 19, 2024
18692775 PD-L1 TARGETING FUSION PROTEINS AND METHODS OF USE THEREOF Gt Biopharma, Inc. BUTTICE, AUDREY L §102§103§112DP Non-Final OA — Pending Mar 15, 2024
18691365 METHOD OF TREATING MULTIPLE MYELOMA Caelum Biosciences, Inc. AEDER, SEAN E §103§112DP Non-Final OA — Pending Mar 12, 2024
18586030 SEQUENTIAL ENCODING METHODS AND RELATED KITS Encodia, Inc. YOUNG, BRIAN ELLIS 1681 §102§103DP Non-Final OA — Pending Feb 23, 2024
18581048 ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE Dechra Limited CHANDRA, GYAN §112DP Non-Final OA — Pending Feb 19, 2024
18683096 COHERENT ISING MACHINE WITH OPTICAL ERROR CORRECTION FOR OPTIMIZATION SOLUTION GENERATOR SYSTEM AND METHOD The University of Tokyo ARJOMANDI, NOOSHA §101§102 Non-Final OA — Pending Feb 12, 2024
18416349 TREATMENT OF EXPOSURE TO VESICANTS Normoxi Inc. CRAIGO, WILLIAM A 1615 §102§112DP Non-Final OA — Pending Jan 18, 2024
18564554 A SUPER-TRAIL MOLECULE COMPRISING TWO TRAIL TRIMERS Bejing Anxinhuaide Biotech. Co., Ltd. PAK, MICHAEL D 1654 §102§103§112 Non-Final OA — Pending Nov 27, 2023
18563854 METHOD OF MATCHING ANALYTICS AND COMMUNICATION ESTABLISHMENT Friendlybuzz Company, Pbc JOSHI, SURAJ M 2447 §103 Final Rejection 59d overdue Pending Nov 22, 2023
18499944 METHODS FOR BIOMOLECULE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS Encodia, Inc. LANKFORD JR, LEON B 1657 §102§103 Non-Final OA — Pending Nov 01, 2023
18384788 Seamless Main Pole Electroplating For A Magnetic Recording Write Head Headway Technologies, Inc. TRINH, MINH N DP Non-Final OA — Pending Oct 27, 2023
18286081 METHOD OF DETECTING CANCER USING GENOME-WIDE CFDNA FRAGMENTATION PROFILES Delfi Diagnostics, Inc. GRAY, JESSICA 1682 §103§112DP Final Rejection — Pending Oct 06, 2023
18549564 METHODS OF TREATMENT FOR LEUKEMIA Dna Seq 2, Inc. JARRELL, NOBLE E 1699 §103 Final Rejection — Pending Sep 07, 2023
18279853 Conductive Biocompatible Scaffold For Electroporation Ana Elena Kadala HASSAN, LIBAN M 1799 §102§103§112 Non-Final OA — Pending Aug 31, 2023
18454292 CRAC CHANNEL INHIBITOR COMPOSITIONS Calcimedica, Inc. WHITE, DAWANNA SHAR-DAY 1627 §103DP Final Rejection — Pending Aug 23, 2023
18274978 EPIGENETIC GENE REGULATION TO TREAT NEUROLOGICAL DISEASES AND PAIN Navega Therapeutics, Inc. HUDSON, AMY ROSE 1636 §103§112DP Non-Final OA — Pending Jul 28, 2023
18352079 SECRETABLE PAYLOAD REGULATION Senti Biosciences, Inc. LEE, JAE W 1656 §103§112 Non-Final OA — Pending Jul 13, 2023
18218953 Accelerometer-Based Voice Activity Detection With Optimized Detection Axis Invensense, Inc. OPSASNICK, MICHAEL N 2658 §102§103 Final Rejection 8d overdue Pending Jul 06, 2023
18038647 METHOD FOR TRAVERSING AN ANATOMICAL VESSEL WALL Mvrx, Inc. RABAGLIA, BRIDGET ELIZABETH 3771 §103 Final Rejection — Pending May 24, 2023
18201129 POLYPEPTIDE MODIFICATION AND CONJUGATION METHODS Encodia, Inc. BEANE, RANDALL L 1654 §102§103§112 Non-Final OA — Pending May 23, 2023
18199154 INDUCIBLE CELL DEATH SYSTEMS Senti Biosciences, Inc. SHUPE, ELIZABETH A 1643 §102§103§112DP Non-Final OA — Pending May 18, 2023
18317195 ENHANCED ERYTHROPOIESIS AND IRON METABOLISM Fibrogen, Inc. SCHMITT, MICHAEL J 1629 Other Non-Final OA 150d overdue Pending May 15, 2023
18144109 AUTOMATIC LINK PREDICTION FOR DEVICES IN COMMERCIAL AND INDUSTRIAL ENVIRONMENTS Mapped Inc. SAXENA, AKASH 2188 §103Other Non-Final OA 73d overdue Pending May 05, 2023
18297914 ARGININE MODIFICATION AND CONJUGATION METHODS Encodia, Inc. HIBBERT, CATHERINE S 1658 §103§112 Non-Final OA — Pending Apr 10, 2023
18122362 Self-Aligned Side Gap Insulator For A Perpendicular Magnetic Recording Writer Headway Technologies, Inc. RENNER, CRAIG A 2688 §102 Final Rejection 23d Pending Mar 16, 2023
18120676 REAGENT CARTRIDGE AND TEMPERATURE CONTROL SYSTEM Encodia, Inc. CHIU, MAY LEUNG 1758 §102§103§112 Non-Final OA — Pending Mar 13, 2023
18111846 BROADCAST DATA, SHARED WEIGHT MULTIPLY-ACCUMULATE Analog Devices, Inc. WAJE, CARLO C §102§103§112Other Non-Final OA — Pending Feb 20, 2023
18018759 COMPOSITIONS AND METHODS FOR IMPROVED VACCINATION Combined Therapeutics, Inc. QIAN, CELINE X 1637 §102§103DP Final Rejection — Pending Jan 30, 2023
18065282 METHODS FOR PROTEIN IDENTIFICATION BASED ON ENCODING REACTIONS Encodia, Inc. PHAM, KHAI QUYNH TIEN 1684 §102§103§112DP Non-Final OA — Pending Dec 13, 2022
18061045 AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USES Aivita Biomedical, Inc. BOESEN, AGNIESZKA 1672 §103 Final Rejection 3d overdue Pending Dec 02, 2022
18056973 METHODS AND COMPOSITIONS FOR TREATING ACUTE KIDNEY INJURY Calcimedica, Inc. RZECZYCKI, PHILLIP MATTHEW 1625 §103 Non-Final OA 15d Pending Nov 18, 2022
17985698 Gold-Copper Alloy In A Heat-Assisted Magnetic Recording Writer Headway Technologies, Inc. CHAU, LINDA N 1785 §103 Non-Final OA — Pending Nov 11, 2022
17921477 METHODS AND SYSTEMS FOR DETERMINATION OF AN EFFECTIVE THERAPEUTIC REGIMEN AND DRUG DISCOVERY Dna-Seq, Inc. ANDERSON-FEARS, KEENAN NEIL 1687 §103 Non-Final OA — Pending Oct 26, 2022
17966681 Shape Memory Alloy Actuators And Methods Thereof Hutchinson Technology Incorporated PICHLER, MARIN 2872 §102§103§112 Non-Final OA — Pending Oct 14, 2022
17918861 VIRAL DELIVERY VEHICLE SELECTION Gordian Biotechnology, Inc. BOESEN, CHRISTIAN C 1684 §101§102 Non-Final OA — Pending Oct 13, 2022
17933463 IMMUNOCONJUGATES TARGETING CD46 AND METHODS OF USE THEREOF Fortis Therapeutics, Inc. CANELLA, KAREN A 1643 §112DP Final Rejection — Pending Sep 19, 2022
17862183 High-Aspect Ratio Electroplated Structures And Anisotropic Electroplating Processes Hutchinson Technology Incorporated WITTENBERG, STEFANIE S 1795 §112 Non-Final OA 29d Pending Jul 11, 2022
17838115 METHOD AND SYSTEM FOR IMPROVED MANAGEMENT OF GENETIC DISEASES Alexion Pharmaceuticals, Inc. MINCHELLA, KAITLYN L 1685 §101§103§112Other Final Rejection 59d overdue Pending Jun 10, 2022
17735835 COMPACT WIRELESS RANGE OF MOTION MEASUREMENT SYSTEM AND METHOD X-Ray Optics, Inc. MCCORMACK, ERIN KATHLEEN 3791 §103 Final Rejection 32d overdue Pending May 03, 2022
17762354 NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE Regents Of The University Of Minnesota BENAVIDES, JENNIFER ANN 1675 §103§112DP Non-Final OA 31d overdue Pending Mar 21, 2022
17511798 Multiplier Circuit Array, MAC and MAC Pipeline including Same, and Methods of Configuring Same Analog Devices, Inc. LE, PHAT NGOC 2182 §103 Final Rejection 26d Pending Oct 27, 2021
17606759 METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE Encodia, Inc. ADAMS, MICHELLE 1797 §112 Non-Final OA 6d Pending Oct 26, 2021
17399920 CLASSIFICATION OF SUBTYPES OF KIDNEY TUMORS USING DNA METHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA GOLDBERG, JEANINE ANNE 1682 §101§112 Non-Final OA 42d overdue Pending Aug 11, 2021
17389222 Swappable Battery System And Method, Electric Vehicles, Battery As A Service (BaaS) Lyves Hatcher Pte. Ltd. ABDULLAEV, AMANULLA 3692 §103 Final Rejection 9d overdue Pending Jul 29, 2021
16866281 METHODS AND SYSTEMS FOR DETERMINATION OF AN EFFECTIVE THERAPEUTIC REGIMEN AND DRUG DISCOVERY Dna-Seq, Inc. LIU, GUOZHEN 1686 §101DP Final Rejection — Pending May 04, 2020
16669251 METHOD OF MANUFACTURING PIEZOELECTRIC MICROACTUATORS HAVING WRAP-AROUND ELECTRODES Magnecomp Corporation CAZAN, LIVIUS RADU 3729 §112 Non-Final OA 30d Pending Oct 30, 2019
16388614 METHOD AND SYSTEM FOR RAPID GENETIC ANALYSIS Rady Children'S Hospital Research Center SABOUR, GHAZAL 1686 §103DP Final Rejection 73d overdue Pending Apr 18, 2019

Managing DLA Piper LLP (US)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month